Amneal Pharmaceuticals, Inc. AMRX Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s interest expense?
- Amneal Pharmaceuticals, Inc. (AMRX) reported interest expense of -$53.36M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s interest expense changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s interest expense increased by 6.3% year-over-year, from -$56.94M to -$53.36M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s interest expense?
- Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s interest expense has grown at a 15.3% compound annual growth rate (CAGR), from -$136.33M to -$241.09M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.